*.*.44.201
药智数据企业版
量身打造,体验升级
立即前往
VIP免费试用申请
登录 注册
当前位置: 首页 > 反馈纠错 帮助中心
(11b)-17-(乙酰氧基)...
CAS号 126784-99-4
中文别名
英文别名 CBD 2914; VA 2914; (11b)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione
分子量 475.62
分子式 C30H37NO4
EINECS编号
综合信息 查看供应
目录导航
提示:点击目录可直接跳转到对应的信息。

物理化学性质

密度 1.19
熔点 183-185 ºC

安全术语
风险术语
上游原料
Bromo[4-(dimethylamino)phenyl]magnesium chloro(chloromethyl)dimethylsilane (13S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one   (13S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one3,3-Ethylenedioxyestra-5(10),9(11)-dien-17-one(8R,13R,14R,17S)-17-ethynyl-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol(8R,13R,14R)-13-methyl-17-(2-(phenylsulfinyl)vinylidene)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolane](8R,13R,14R)-17-(1-methoxyvinyl)-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol1-((8R,13R,14R)-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone   (13S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one3,3-Ethylenedioxyestra-5(10),9(11)-dien-17-one1-(7-methyl-3,4,6,7,8,8a,9,10-octahydro-1H-spiro[4a,10a-epoxyphenanthrene-2,2'-[1,3]dioxolan]-7-yl)ethanone(2S)-2-hydroxy-2-((7R,8aR)-7-methyl-3,4,6,7,8,8a,9,10-octahydro-1H-spiro[4a,10a-epoxyphenanthrene-2,2'-[1,3]dioxolan]-7-yl)propanenitrile(2S)-2-((7R,8aR)-7-methyl-3,4,6,7,8,8a,9,10-octahydro-1H-spiro[4a,10a-epoxyphenanthrene-2,2'-[1,3]dioxolan]-7-yl)-2-((trimethylsilyl)oxy)propanenitrile(2S)-2-((7'S,8a'R,10a'S)-5'-(4-(dimethylamino)phenyl)-10a'-hydroxy-7'-methyl-3',4',5',6',7',8',8a',9',10',10a'-decahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthren]-7'-yl)-2-((trimethylsilyl)oxy)propanenitrile(2S)-2-((7'S,8a'R,10a'S)-5'-(4-(dimethylamino)phenyl)-10a'-hydroxy-7'-methyl-3',4',5',6',7',8',8a',9',10',10a'-decahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthren]-7'-yl)-2-((trimethylsilyl)oxy)propanenitrile(7S)-7-((2S,3R)-2,3-dihydroxy-4-methoxybutan-2-yl)-5-(4-(dimethylamino)phenyl)-7-methyl-3,4,6,7,8,8a,9,10-octahydrophenanthren-2(5H)-one(7S)-5-(4-(dimethylamino)phenyl)-7-((S)-2-hydroxy-4-methoxy-3-oxobutan-2-yl)-7-methyl-3,4,6,7,8,8a,9,10-octahydrophenanthren-2(5H)-one(13S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one(13R,17S)-17-acetyl-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate1-((8R,13R,14R)-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone1-((5S,10S,13R,17S)-17-hydroxy-13- methyl-1,2,4,6,7,8,12,13,14,15,16,17- dodecahydrospiro[5,10-epoxycyclopenta[a] phenanthrene-3,2'-[1,3]dioxolan]-17-yl)ethanone1-((5S,13R,17S)-11-(4-(dimethylamino) phenyl)-5,17-dihydroxy-13-methyl- 1,2,4,5,6,7,8,11,12,13,14,15,16,17- tetradecahydrospiro[cyclopenta[a]phenanthrene-3,2'- [1,3]dioxolan]-17-yl)ethanone  (13S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one   (13S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one